HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of biomarkers in patients with dyspnea.

AbstractBACKGROUND:
The use of biomarkers has been demonstrated useful in many acute diseases both for diagnosis, prognosis and risk stratification.
OBJECTIVES:
The purpose of this review is to analyze several biomarkers of potential use in patients referring to Emergency Department with acute dyspnea.
STATE OF THE ART:
The role of natriuretic peptides has a proven utility in the diagnosis, risk stratification, patient management and prediction of outcome in acute and chronic heart failure (HF). New immunoassays are available for the detection of mid-region prohormones in patients with acute dyspnea such as Mid-region pro-adrenomedullin (MR-proADM) and Mid-region pro-atrial natriuretic peptide (MR-proANP). Also procalcitonin, copeptin and D-dimer, which are markers of inflammation, bacterial infections and sepsis, seem to be useful in the differential diagnosis of dyspnea. Conventional and high-sensitivity troponins are fundamental, not only in the diagnosis of acute coronary syndromes, but also as indicators of mortality in patients with acute decompensated heart failure.
PERSPECTIVES:
Further studies with randomized controlled clinical trials will be needed to prove the theoretical clinical advantages offered by a shortness of breath biomarkers in terms of diagnostic, prognostic, cost effective work-up and management of patients with acute dyspnea.
CONCLUSIONS:
A multimarker pannel approach performed by rapid and accurate assays could be useful for emergency physicians to promptly identify different causes of dyspnea thus managing to improve diagnosis, treatment and risk stratification.
AuthorsC S Gori, L Magrini, F Travaglino, S Di Somma
JournalEuropean review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci) Vol. 15 Issue 2 Pg. 229-40 (Feb 2011) ISSN: 1128-3602 [Print] Italy
PMID21434492 (Publication Type: Journal Article, Review)
Chemical References
  • Biomarkers
  • CALCA protein, human
  • Fibrin Fibrinogen Degradation Products
  • Peptide Fragments
  • Protein Precursors
  • Troponin T
  • fibrin fragment D
  • midregional pro-atrial natriuretic peptide, human
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
  • Adrenomedullin
  • Atrial Natriuretic Factor
  • Calcitonin
  • Calcitonin Gene-Related Peptide
Topics
  • Acute Disease
  • Adrenomedullin (blood)
  • Atrial Natriuretic Factor (blood)
  • Biomarkers (blood)
  • Calcitonin (blood)
  • Calcitonin Gene-Related Peptide
  • Dyspnea (blood, diagnosis)
  • Fibrin Fibrinogen Degradation Products (analysis)
  • Humans
  • Natriuretic Peptide, Brain (blood)
  • Peptide Fragments (blood)
  • Protein Precursors (blood)
  • Troponin T (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: